Designing and Evaluating a Prediabetes Shared Decision Aid

Beth A Careyva1, Kyle Shaak2, Nicole M Burgess2

  • 1From the Lehigh valley health network, Department of Family Medicine, Allentown, PA (BAC, KS, NMB, MBJ, ESB, YC); Moravian College, Bethlehem, PA (AND, CP). beth_a.careyva@lvhn.org.

Insights

A new shared decision aid effectively prepared patients and clinicians for prediabetes discussions in primary care. This tool may help reduce progression to diabetes and its associated health risks.

Area of Science:

  • Public Health
  • Clinical Decision-Making
  • Health Informatics

Background:

  • Prediabetes prevalence is rising, increasing risks for diabetes, heart disease, stroke, and retinopathy.
  • Clinicians lack effective tools for discussing prediabetes during primary care visits.

Purpose of the Study:

  • Develop a prediabetes shared decision aid with patient and stakeholder input.
  • Evaluate the feasibility and user experience of implementing this tool in primary care.

Main Methods:

  • A Patient and Stakeholder Advisory Committee (PASAC) co-created a decision aid infographic.
  • The tool was tested by 5 clinicians with 50 prediabetes patients across 3 primary care practices.
  • Patient and clinician surveys assessed feasibility, experience, and preparedness.

Main Results:

  • The decision aid was developed through a collaborative PASAC process.
  • 96% of patients felt prepared to plan diabetes prevention.
  • 100% of clinicians would reuse the tool, finding it did not increase visit length.

Conclusions:

  • Co-creating and implementing a prediabetes shared decision aid in primary care is feasible.
  • The tool facilitated patient-clinician discussions, potentially mitigating diabetes progression.
  • Further research should identify key intervention components for promoting prediabetes discussions.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
786
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
762
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
268
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K